查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1351107

2030 年臨床試驗包裝市場預測：依部門市場和地區分類的全球分析

Clinical Trial Packaging Market Forecasts to 2030 - Global Analysis By Product Type, Clinical Trial Type, Material, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 175+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC預測，2023年全球臨床試驗包裝市場規模將達到30.4億美元，預計在預測期內將以12.7%的年複合成長率成長，到2030年達到70.3億美元。

臨床試驗產品使用臨床試驗包裝解決方案進行包裝、儲存、保護和運輸。進行臨床試驗來評估藥物的有效性並確定各種藥物製劑的最佳劑量。臨床試驗中使用多種產品，包括注射器、瓶子、泡罩、管子、安瓿和小瓶、袋子和小袋以及小袋。此外，這些產品需要特殊包裝，因為標準包裝會對臨床試驗結果產生負面影響，尤其是敏感藥物。

根據美國消費品安全委員會的規定，可以選擇的方案必須包括醫生參與評估對個別患者的藥物配發。

生技藥品革命與個人化醫療

單株抗體、細胞療法和基因療法等生技藥品的發展徹底改變了臨床試驗領域。為了保持穩定性和完整性，這些最先進治療通常需要專門的包裝解決方案。此外，由於個人化醫療（針對特定患者調整治療方法），包裝需求變得更加多樣化。需要特殊的包裝解決方案來適應不同的給藥、配方和給藥方法。

與永續性相關的環境議題

臨床試驗包裝市場的一個主要障礙是對環境永續性的日益關注。為了減少對環境的影響，公司面臨越來越大的壓力，需要採取環保包裝策略。此外，開發和實施這些環保包裝方案的成本可能很高，即使符合全球環境目標，也會影響報酬率和營運費用。

數位科技的整合

臨床試驗包裝透過整合數位技術提供了重要的機會。用於安全資料共用的區塊鏈、用於改進可追溯性的二維碼以及具有即時監控功能的物聯網包裝等創新正在徹底改變包裝產業。此外，使用這些技術的包裝公司可以透過減少錯誤和提高效率來改善其臨床試驗供應鏈。

原料成本上漲

臨床試驗包裝市場不斷受到塑膠、金屬和特殊包裝零件等原料價格波動的威脅。價格快速上漲會降低報酬率並影響整個包裝解決方案的成本效益。此外，公司需要製定有效的籌資策略並密切監控原料市場以減輕此威脅。這使您可以控制成本波動。

COVID-19 的影響：

臨床試驗包裝市場受到 COVID-19大流行的嚴重影響。由於全球供應鏈和製造程序中斷，包裝供應的最初延誤和短缺影響了臨床試驗的及時完成。此外，嚴格的封鎖程序和旅行限制阻礙了臨床試驗材料的分發，造成後勤困難。然而，疫情也加速了整個產業的數位化配合措施，促使遠端監控和智慧包裝技術的採用。

預計瓶裝領域在預測期內將是最大的市場

預計瓶裝細分市場在預測期內將佔據最大佔有率。各種類型的藥品都包裝在瓶子裡，包括內服藥物、液體藥品，甚至是錠劑、膠囊等固態藥品。該瓶子適應性強，易於使用，可滿足各種儲存和分配要求。此外，瓶子有多種尺寸和材料，使製藥公司能夠選擇滿足其產品特定需求的包裝選項。

臨床研究機構部門預計在預測期內年複合成長率最高

在臨床試驗包裝市場中，臨床研究機構細分市場在預測期內的年複合成長率最高。為了製藥和生物技術公司的利益，CRO 對於進行臨床試驗至關重要。 CRO 管理大部分臨床研究業務，包括病患招募、資料管理和法規合規性。此外，製藥和生物技術公司擴大將臨床試驗業務委託給 CRO，以節省成本並獲得專業知識，這推動了 CRO 的顯著成長。臨床試驗數量的增加以及對臨床試驗包裝服務需求的增加也促進了 CRO 領域的成長。

佔比最高的地區

臨床試驗包裝的最大市場佔有率在北美，尤其美國。北美的優勢在於其蓬勃發展的生物技術和製藥行業、廣泛的臨床試驗活動、完善的法規結構以及對研發的大量投資。此外，該地區先進的醫療保健系統和對創新的承諾使其成為臨床試驗包裝的世界領導者。

複合年複合成長率最高的地區：

預計亞太地區的臨床試驗包裝市場年複合成長率最高。該地區龐大且多樣化的患者群體、快速成長的製藥和生物技術產業以及醫療基礎設施投資的增加要素了成長。此外，一些亞洲國家的製造和包裝的可負擔性增加了該地區作為臨床試驗包裝服務來源的吸引力。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球臨床試驗包裝市場：依產品類型

  • 注射器
  • 小瓶和安瓿
  • 瓶子
  • 袋/袋
  • 水皰
    • 冷成型
    • 熱成型
  • 管子
  • 香囊
  • 套件或包
  • 其他產品類型

第6章 全球臨床試驗包裝市場：依臨床試驗類型

  • 治療和預防
    • 疫苗
    • 藥物研發發現與開發
    • 治療設備
    • 生物相似藥
    • 治療測定
    • 治療性治療
  • 診斷
    • 診斷分析
    • 診斷設備
  • 其他臨床試驗類型

第7章 全球臨床試驗包裝市場：依材料分類

  • 塑膠
    • 聚氯乙烯（PVC）
    • 聚乙烯（PE）
      • 高密度聚苯乙烯（HDPE）
      • 低密度聚乙烯（LDPE）
    • 聚丙烯（PP）
  • 玻璃
  • 金屬
  • 紙
  • 紙板
  • 其他材料

第8章 全球臨床試驗包裝市場：依最終使用者分類

  • 研究實驗室
  • 臨床研究組織
  • 藥品生產設施
  • 製藥公司
  • 生技公司
  • 學術研究所
  • 醫院和診所
  • 其他最終用戶

第9章 全球臨床試驗包裝市場：依地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章公司簡介

  • PCI Pharma Services
  • Schreiner MediPharm
  • Berry Global, Inc.
  • 3M Company
  • Nupharm Group
  • Catalent, Inc.
  • Sharp Clinical Services, Inc.
  • Korber Medipak Systems AG
  • Parexel International Corporation
  • Alcami Corporation, Inc.
  • Reed-Lane, Inc.
  • Aphena Pharma Solutions
  • Symbiosis Pharmaceutical Services
  • Carton Service, Inc.
  • Piramal Pharma Solutions
  • Thermo Fisher Scientific Inc.
  • Xerimis Inc.
  • NextPharma Technologies Holding Limited
  • WestRock Company
  • Sentry BioPharma Services, Inc.
  • Yourway Transport Inc.
Product Code: SMRC23794

According to Stratistics MRC, the Global Clinical Trial Packaging Market is accounted for $3.04 billion in 2023 and is expected to reach $7.03 billion by 2030 growing at a CAGR of 12.7% during the forecast period. Clinical trial products are packaged, stored, protected, and transported using clinical trial packaging solutions. Clinical trials are conducted to evaluate a drug's effectiveness and determine the best dose for various pharmaceutical formulations. Clinical trials involve the use of a wide range of products, including syringes, bottles, blisters, tubes, ampoules and vials, bags and pouches, and sachets. Moreover, these products require special packaging because standard packaging has a negative impact on clinical trial outcomes, particularly for highly sensitive drugs.

According to CPSC, the options available to us must incorporate physician involvement in assessing dispensation of drug to individual patients.

Market Dynamics:

Driver:

Revolution in biologics and personalized medicine

With the development of biologics like monoclonal antibodies, cell therapies, and gene therapies, the field of clinical trials has undergone significant change. To maintain their stability and integrity, these cutting-edge therapies frequently need specialized packaging solutions. Additionally, the packaging requirements have become even more varied as a result of personalized medicine, which adapts treatments to specific patients. To accommodate various dosages, formulations, and administration techniques, specialized packaging solutions are required.

Restraint:

Environmental concerns with sustainability

A significant barrier to the market for clinical trial packaging is the increasing focus on environmental sustainability. In order to lessen their impact on the environment, businesses are under increasing pressure to adopt eco-friendly packaging strategies. Furthermore, the cost of developing and implementing these environmentally friendly packaging options may be higher, which will have an impact on profit margins and operating expenses even though they are in line with global environmental goals.

Opportunity:

Integration of digital technologies

Clinical trial packaging offers significant opportunities when digital technologies are incorporated. Innovations like blockchain for secure data sharing, QR codes for improved traceability, and IoT-enabled packaging with real-time monitoring capabilities are revolutionizing the packaging industry. Moreover, packaging companies that use these technologies can improve supply chains for clinical trials by doing so while lowering errors and increasing efficiency.

Threat:

Rising costs of raw materials

The clinical trial packaging market is constantly threatened by changes in the price of raw materials like plastics, metals, and specialty packaging components. Sudden price increases can reduce profit margins, which affects how cost-effective packaging solutions are overall. Additionally, companies need to establish effective procurement strategies and closely monitor the markets for raw materials to reduce this threat. This will help them control cost fluctuations.

COVID-19 Impact:

The clinical trial packaging market was significantly affected by the COVID-19 pandemic. Initial delays and shortages in packaging supplies had an impact on the timely completion of clinical trials due to disruptions in global supply chains and manufacturing procedures. Furthermore, the distribution of clinical trial materials was hampered by strict lockdown procedures and travel restrictions, creating logistical difficulties. But the pandemic also sped up industry wide efforts to transform digitally, leading to the adoption of remote monitoring and smart packaging technologies.

The Bottles segment is expected to be the largest during the forecast period

During the forecast period, it is anticipated that the bottle segment will hold the largest share. Many different types of medications, including oral medications, liquids, and even solid dosage forms like tablets and capsules, are packaged in bottles. They are adaptable, simple to use, and can accommodate various storage and dispensing requirements. Additionally, bottles are available in a range of sizes and materials, so pharmaceutical companies can select packaging options that meet the particular needs of their products.

The Clinical Research Organizations segment is expected to have the highest CAGR during the forecast period

In the market for clinical trial packaging, the clinical research organization segment is growing at the highest CAGR during the anticipated period. For the benefit of pharmaceutical and biotechnology companies, CROs are essential in carrying out clinical trials. They manage a sizable portion of clinical research tasks, such as patient recruitment, data management, and legal compliance. Furthermore, Pharmaceutical and biotechnology companies are increasingly outsourcing clinical trial activities to CROs due to cost savings and specialized knowledge, which is fueling these companies' remarkable growth. The growing number of clinical trials and the increase in demand for clinical trial packaging services also contributed to the growth of the CRO segment.

Region with largest share:

The largest market share for clinical trial packaging was held by North America, particularly the United States. North America's dominance can be attributed to its thriving biotechnology and pharmaceutical industries, extensive clinical trial activities, well-established regulatory framework, and substantial investments in research and development. Moreover, this region leads the world in clinical trial packaging due to its sophisticated healthcare system and commitment to innovation.

Region with highest CAGR:

In the market for clinical trial packaging, the Asia-Pacific region is expected to have the highest CAGR. The region's large and diverse patient population and the burgeoning pharmaceutical and biotechnology industries were the main drivers of this growth, as were raising investments in healthcare infrastructure. Additionally, some Asian nation's affordable manufacturing and packaging options added to the region's appeal as a source of clinical trial packaging services.

Key players in the market:

Some of the key players in Clinical Trial Packaging market include: PCI Pharma Services, Schreiner MediPharm, Berry Global, Inc., 3M Company, Nupharm Group , Catalent, Inc. , Sharp Clinical Services, Inc. , Korber Medipak Systems AG, Parexel International Corporation , Alcami Corporation, Inc., Reed-Lane, Inc., Aphena Pharma Solutions, Symbiosis Pharmaceutical Services, Carton Service, Inc., Piramal Pharma Solutions , Thermo Fisher Scientific Inc., Xerimis Inc., NextPharma Technologies Holding Limited, WestRock Company, Sentry BioPharma Services, Inc. and Yourway Transport Inc.

Key Developments:

In May 2023, 3M today announced it has entered into agreements to sell certain assets associated with its dental local anesthetic portfolio, based in Seefeld, Germany, to Pierrel S.p.A., a global provider of services for the pharmaceutical industry, for a purchase price of $70 million, subject to closing and other adjustments.

In May 2023, Schreiner MediPharm has introduced a counterfeit and tampering protection solution whose void effect makes it exceedingly difficult for counterfeiters to successfully reuse original packaging. The company's tailored Void-Labels make previously covert messages readily visible upon peeling, making a package's first opening clearly and irreversibly apparent.

In April 2023, PCI Pharma Services (PCI), a leading global contract development and manufacturing organization announced that three new state-of-the-arts automated sterile fill-finish machines at its San Diego and Melbourne facilities are now fully operational. The innovative machinery from Cytiva can be used to fill various sterile medications into vials and syringes for small-to-mid scale client needs.

Product Types Covered:

  • Syringes
  • Vials & Ampoules
  • Bottles
  • Bags & Pouches
  • Blisters
  • Tubes
  • Sachets
  • Kits or Packs
  • Other Product Types

Clinical Trial Types Covered:

  • Therapeutic and Prevention
  • Diagnostics
  • Other Clinical Trail Types

Materials Covered:

  • Plastic
  • Glass
  • Metal
  • Paper
  • Corrugated Fiber
  • Other Materials

End Users Covered:

  • Research Laboratories
  • Clinical Research Organizations
  • Drug Manufacturing Facilities
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic & Research Institutes
  • Hospitals & Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Clinical Trial Packaging Market, By Product Type

  • 5.1 Introduction
  • 5.2 Syringes
  • 5.3 Vials & Ampoules
  • 5.4 Bottles
  • 5.5 Bags & Pouches
  • 5.6 Blisters
    • 5.6.1 Cold Forming
    • 5.6.2 Thermoforming
  • 5.7 Tubes
  • 5.8 Sachets
  • 5.9 Kits or Packs
  • 5.10 Other Product Types

6 Global Clinical Trial Packaging Market, By Clinical Trial Type

  • 6.1 Introduction
  • 6.2 Therapeutic and Prevention
    • 6.2.1 Vaccines
    • 6.2.2 Drug Discovery and Development
    • 6.2.3 Therapeutic Devices
    • 6.2.4 Biosimilars
    • 6.2.5 Therapeutic Assays
    • 6.2.6 Therapeutic Procedures
  • 6.3 Diagnostics
    • 6.3.1 Diagnostic Assay
    • 6.3.2 Diagnostic Devices
  • 6.4 Other Clinical Trail Types

7 Global Clinical Trial Packaging Market, By Material

  • 7.1 Introduction
  • 7.2 Plastic
    • 7.2.1 Polyvinyl Chloride (PVC)
    • 7.2.2 Polyethylene (PE)
      • 7.2.2.1 High Density Polyethylene (HDPE)
      • 7.2.2.2 Low Density Polyethylene (LDPE)
    • 7.2.3 Polypropylene (PP)
  • 7.3 Glass
  • 7.4 Metal
  • 7.5 Paper
  • 7.6 Corrugated Fiber
  • 7.7 Other Materials

8 Global Clinical Trial Packaging Market, By End User

  • 8.1 Introduction
  • 8.2 Research Laboratories
  • 8.3 Clinical Research Organizations
  • 8.4 Drug Manufacturing Facilities
  • 8.5 Pharmaceutical Companies
  • 8.6 Biotechnology Companies
  • 8.7 Academic & Research Institutes
  • 8.8 Hospitals & Clinics
  • 8.9 Other End Users

9 Global Clinical Trial Packaging Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 PCI Pharma Services
  • 11.2 Schreiner MediPharm
  • 11.3 Berry Global, Inc.
  • 11.4 3M Company
  • 11.5 Nupharm Group
  • 11.6 Catalent, Inc.
  • 11.7 Sharp Clinical Services, Inc.
  • 11.8 Korber Medipak Systems AG
  • 11.9 Parexel International Corporation
  • 11.10 Alcami Corporation, Inc.
  • 11.11 Reed-Lane, Inc.
  • 11.12 Aphena Pharma Solutions
  • 11.13 Symbiosis Pharmaceutical Services
  • 11.14 Carton Service, Inc.
  • 11.15 Piramal Pharma Solutions
  • 11.16 Thermo Fisher Scientific Inc.
  • 11.17 Xerimis Inc.
  • 11.18 NextPharma Technologies Holding Limited
  • 11.19 WestRock Company
  • 11.20 Sentry BioPharma Services, Inc.
  • 11.21 Yourway Transport Inc.

List of Tables

  • Table 1 Global Clinical Trial Packaging Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Clinical Trial Packaging Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Clinical Trial Packaging Market Outlook, By Syringes (2021-2030) ($MN)
  • Table 4 Global Clinical Trial Packaging Market Outlook, By Vials & Ampoules (2021-2030) ($MN)
  • Table 5 Global Clinical Trial Packaging Market Outlook, By Bottles (2021-2030) ($MN)
  • Table 6 Global Clinical Trial Packaging Market Outlook, By Bags & Pouches (2021-2030) ($MN)
  • Table 7 Global Clinical Trial Packaging Market Outlook, By Blisters (2021-2030) ($MN)
  • Table 8 Global Clinical Trial Packaging Market Outlook, By Cold Forming (2021-2030) ($MN)
  • Table 9 Global Clinical Trial Packaging Market Outlook, By Thermoforming (2021-2030) ($MN)
  • Table 10 Global Clinical Trial Packaging Market Outlook, By Tubes (2021-2030) ($MN)
  • Table 11 Global Clinical Trial Packaging Market Outlook, By Sachets (2021-2030) ($MN)
  • Table 12 Global Clinical Trial Packaging Market Outlook, By Kits or Packs (2021-2030) ($MN)
  • Table 13 Global Clinical Trial Packaging Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 14 Global Clinical Trial Packaging Market Outlook, By Clinical Trial Type (2021-2030) ($MN)
  • Table 15 Global Clinical Trial Packaging Market Outlook, By Therapeutic and Prevention (2021-2030) ($MN)
  • Table 16 Global Clinical Trial Packaging Market Outlook, By Vaccines (2021-2030) ($MN)
  • Table 17 Global Clinical Trial Packaging Market Outlook, By Drug Discovery and Development (2021-2030) ($MN)
  • Table 18 Global Clinical Trial Packaging Market Outlook, By Therapeutic Devices (2021-2030) ($MN)
  • Table 19 Global Clinical Trial Packaging Market Outlook, By Biosimilars (2021-2030) ($MN)
  • Table 20 Global Clinical Trial Packaging Market Outlook, By Therapeutic Assays (2021-2030) ($MN)
  • Table 21 Global Clinical Trial Packaging Market Outlook, By Therapeutic Procedures (2021-2030) ($MN)
  • Table 22 Global Clinical Trial Packaging Market Outlook, By Diagnostics (2021-2030) ($MN)
  • Table 23 Global Clinical Trial Packaging Market Outlook, By Diagnostic Assay (2021-2030) ($MN)
  • Table 24 Global Clinical Trial Packaging Market Outlook, By Diagnostic Devices (2021-2030) ($MN)
  • Table 25 Global Clinical Trial Packaging Market Outlook, By Other Clinical Trail Types (2021-2030) ($MN)
  • Table 26 Global Clinical Trial Packaging Market Outlook, By Material (2021-2030) ($MN)
  • Table 27 Global Clinical Trial Packaging Market Outlook, By Plastic (2021-2030) ($MN)
  • Table 28 Global Clinical Trial Packaging Market Outlook, By Polyvinyl Chloride (PVC) (2021-2030) ($MN)
  • Table 29 Global Clinical Trial Packaging Market Outlook, By Polyethylene (PE) (2021-2030) ($MN)
  • Table 30 Global Clinical Trial Packaging Market Outlook, By Polypropylene (PP) (2021-2030) ($MN)
  • Table 31 Global Clinical Trial Packaging Market Outlook, By Glass (2021-2030) ($MN)
  • Table 32 Global Clinical Trial Packaging Market Outlook, By Metal (2021-2030) ($MN)
  • Table 33 Global Clinical Trial Packaging Market Outlook, By Paper (2021-2030) ($MN)
  • Table 34 Global Clinical Trial Packaging Market Outlook, By Corrugated Fiber (2021-2030) ($MN)
  • Table 35 Global Clinical Trial Packaging Market Outlook, By Other Materials (2021-2030) ($MN)
  • Table 36 Global Clinical Trial Packaging Market Outlook, By End User (2021-2030) ($MN)
  • Table 37 Global Clinical Trial Packaging Market Outlook, By Research Laboratories (2021-2030) ($MN)
  • Table 38 Global Clinical Trial Packaging Market Outlook, By Clinical Research Organizations (2021-2030) ($MN)
  • Table 39 Global Clinical Trial Packaging Market Outlook, By Drug Manufacturing Facilities (2021-2030) ($MN)
  • Table 40 Global Clinical Trial Packaging Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
  • Table 41 Global Clinical Trial Packaging Market Outlook, By Biotechnology Companies (2021-2030) ($MN)
  • Table 42 Global Clinical Trial Packaging Market Outlook, By Academic & Research Institutes (2021-2030) ($MN)
  • Table 43 Global Clinical Trial Packaging Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 44 Global Clinical Trial Packaging Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.